Literature DB >> 35702644

We Should Not Use Randomization Procedures to Allocate Scarce Life-Saving Resources.

Roberto Fumagalli1.   

Abstract

In the recent literature across philosophy, medicine and public health policy, many influential arguments have been put forward to support the use of randomization procedures (RAND) to allocate scarce life-saving resources (SLSR). In this paper, I provide a systematic categorization and a critical evaluation of these arguments. I shall argue that those arguments justify using RAND to allocate SLSR in fewer cases than their proponents maintain and that the relevant decision-makers should typically allocate SLSR directly to the individuals with the strongest claims to these resources rather than use RAND to allocate such resources.
© The Author(s) 2021. Published by Oxford University Press.

Entities:  

Year:  2021        PMID: 35702644      PMCID: PMC9188376          DOI: 10.1093/phe/phab025

Source DB:  PubMed          Journal:  Public Health Ethics        ISSN: 1754-9973            Impact factor:   2.706


Introduction

During the COVID-19 pandemic emergency, dramatic increases in the demand for intensive care units have occurred worldwide (e.g. Antommaria ; White and Lo, 2020). In several countries, the number of patients needing intensive care exceeded the number of available intensive care units, forcing medical personnel to make thorny triage decisions (e.g. Cook, 2020; Truog ). Most of the criteria proposed for allocating scarce intensive care units involve a combination of medical need, various clinical factors (e.g. presence and severity of other medical conditions, expected speed of recovery) and some randomization procedures (henceforth, RAND; e.g. British Medical Association, 2020a,b; Chisholm, 2020; Emanuel ). The use of RAND has been advocated to allocate many types of scarce life-saving resources (henceforth, SLSR) besides intensive care units (e.g. urgent organs for transplant, vaccines, organ replacement therapy). In the recent literature across philosophy, medicine and public health policy, many influential arguments have been put forward to support the use of RAND to allocate SLSR (e.g. Sher, 1980; Broome, 1984a,b, 1991a, b; Elster, 1988; Waring, 2004; Saunders, 2009). The idea is that in cases where dividing the available SLSR among the individuals in need is impossible or significantly reduces SLSR’s expected benefits, the relevant decision-makers (e.g. individual doctors, ethical committees, governmental organizations) should allocate SLSR on the basis of RAND (e.g. Glover, 1977; Kornhauser and Sager, 1988; Goodwin, 1992; Hooker, 2005; Stone, 2007, 2011). In this paper, I provide a systematic categorization and a critical evaluation of the most influential arguments that have been put forward to support the use of RAND to allocate SLSR. I shall examine in turn: the argument from convenience; the argument from tie-breaking; the argument from equal chances; the argument from fairness; the argument from incommensurability; and the argument from unjust discrimination. I shall argue that these arguments justify using RAND to allocate SLSR in fewer cases than their proponents maintain and that the relevant decision-makers should typically allocate SLSR directly to the individuals with the strongest claims to SLSR, i.e. use what I call direct allocation procedures (henceforth, DIR) rather than RAND to allocate SLSR. To be sure, my claim is not that all DIR are more justified allocation procedures than RAND. For in many allocation problems, one may identify several DIR that are less justified than RAND (e.g. think of DIR grounded on racist criteria). Rather, my point is that in most allocations of SLSR, one may identify at least some DIR that are more justified than RAND and should therefore use such DIR to allocate the available SLSR. If correct, my claim that the relevant decision-makers should typically use DIR (rather than RAND) to allocate SLSR has widespread implications not just for the individuals involved in these allocations, but also for public policy and clinical practice across the biomedical/the health sciences. For as illustrated in the coming sections, many proposals for allocating SLSR in public policy and the biomedical/the health sciences rest on presuppositions concerning the relative merits of DIR and RAND. Before proceeding, three preliminary remarks are in order. First, I speak of SLSR broadly to encompass a wide range of medical treatments and therapies that are critical to patients’ survival (e.g. intensive care units, urgent organs for transplant, vaccines, organ replacement therapy). Moreover, I use the term RAND to indicate allocation procedures that are designed to yield specific distributions of the chances that the involved individuals have of receiving the available SLSR (e.g. tossing a coin, rolling a die, picking balls from urns). Some RAND (henceforth, weighted RAND) apportion each individual’s chance of receiving the available SLSR to the strength of this individual’s claim to such SLSR. Other RAND (henceforth, unweighted RAND) give to each of the involved individuals an equal chance of receiving the available SLSR irrespective of how strong each individual’s claim to such SLSR is. Yet, by design, neither weighted nor unweighted RAND allow the relevant decision-makers to directly determine which individuals will receive the available SLSR before such RAND are implemented (e.g. Stone, 2011: ch. 2; also ‘Argument from Unjust Discrimination' on the ‘sanitizing’ function of lotteries). Second, I use the term DIR to indicate allocation procedures that give SLSR directly to the individuals with the strongest claims to these SLSR rather than allocate such SLSR on the basis of RAND (e.g. allocation procedures based on medical need and clinical factors such as presence and severity of other medical conditions and expected speed of recovery). Designing and implementing DIR require the relevant decision-makers to rank the involved individuals according to the strength of their claims to the available SLSR and allocate these SLSR to the individuals with the strongest claims to such SLSR. RAND and DIR may occasionally support similar (or even identical) allocations of the available SLSR. Even so, profound differences remain in the justificatory principles which ground the use of RAND and DIR, respectively. For on DIR, the strength of individuals’ claims to the available SLSR directly determines not only what chances these individuals have of receiving these SLSR, but also which individuals will receive such SLSR (e.g. Broome, 1991a: 98; Hooker, 2005: 348–349). Below I argue that the relevant decision-makers should typically use DIR (rather than RAND) to allocate SLSR, but I do not take a position about the issue of which DIR should be used to allocate specific SLSR. In particular, my call for DIR is compatible with the pluralist view that which DIR should be used in a given allocation problem may depend on various contextual features of such problem, including what type of SLSR is allocated (e.g. urgent organs for transplant versus intensive care units), how much the involved individuals’ claims differ in strength, and how stringent the scarcity constraints faced by the relevant decision-makers are. And third, there are many clinical and non-clinical grounds (e.g. medical need and conditions, age, desert, rights, willingness to pay, waiting time) on which one might ascribe to individuals claims to SLSR (e.g. Basson, 1979; Broome, 1991a; Elhauge, 1994; Schmidt, 1998; Harris and Erin, 2002; Persad ; Savulescu ; John and Millum, 2020; Wilkinson ). Still, not all the reasons that an individual may have for receiving SLSR ground claims to such SLSR (e.g. the mere fact that an individual thinks that she would benefit from receiving some SLSR does not per se ground a claim to such SLSR). I am not concerned here with demarcating which particular reasons ground claims to SLSR and what factors determine the strength of individuals’ claims to SLSR in specific allocation problems (e.g. Broome, 2004; Childress and Beauchamp, 2009; Voorhoeve, 2014; Sharadin, 2016; Emanuel , for recent discussion). For my evaluation, it suffices to note that if an individual has a claim to some SLSR, then there is a reason to think that the individual ought to receive this SLSR, but there may be overarching reasons not to give such SLSR to the individual (e.g. Broome, 1994; Stone, 2011: ch. 4; Tomlin, 2012; Kirkpatrick and Eastwood, 2015, on cases where other individuals have stronger claims to the available SLSR).

Argument from Convenience

The argument from convenience holds that the relevant decision-makers should use RAND (rather than DIR) to allocate SLSR on the alleged ground that designing and implementing RAND is typically less costly and time-consuming than designing and implementing DIR (e.g. Persad ; also Duxbury, 1999: 72, claiming that it is ‘appropriate and beneficial to resort to [RAND] where a cost-effective method of decision-making is required’). The idea is that acquiring the information required to establish which candidates have the strongest claims to SLSR is ‘expensive and time consuming’ and that RAND avoid ‘the costs […] of deliberate selection’ (Broome, 1991a: 88; also Elster, 1988: 169, claiming that RAND are ‘rationally prescribed […] because of their simplicity and universal applicability’). There are at least two reasons to doubt that the argument from convenience justifies using RAND (rather than DIR) to allocate SLSR. First, convenience is not the only factor that bears on the justifiability of the available procedures for allocating SLSR. In particular, time and resources are rarely so limited that they prevent the relevant decision-makers from being able to assess how the available allocation procedures fare in terms of factors other than convenience (e.g. fairness). To be sure, one can envision situations where convenience considerations have paramount importance (e.g. think of situations of unforeseen emergency where the relevant decision-makers have limited time and resources to assess different allocation procedures). Still, even in those situations, the relevant decision-makers typically have sufficient time and resources to examine at least some of the factors besides convenience that bear on the justifiability of the available allocation procedures (e.g. medical need and various clinical factors). And considerations of these factors often enable the relevant decision-makers to make some informed ordinal judgements regarding the strength of the involved individuals’ claims to SLSR (e.g. Antommaria ; Chisholm, 2020, on doctors’ widespread reliance on considerations of medical need and various clinical factors to allocate intensive care units during the first wave of the COVID-19 pandemic emergency). And second, even if convenience was the main factor that bears on the justifiability of the available procedures for allocating SLSR, convenience considerations rarely (if ever) justify using RAND to allocate SLSR. For there are plenty of different (weighted and unweighted) RAND one could use in a given allocation problem. And establishing which RAND are justifiably adopted in a given allocation problem (e.g. weighted versus unweighted RAND, which weighted or unweighted RAND) requires the relevant decision-makers to determine how much the involved individuals’ claims to the available SLSR differ in strength and how exactly such differences bear on the justifiability of the proposed RAND (e.g. Den Hartogh, 2004: 17). Regrettably, determining how much the involved individuals’ claims to the available SLSR differ in strength and how exactly such differences bear on the justifiability of the proposed RAND requires time and resources. And for all the argument from convenience shows, RAND may commonly be as costly as DIR in terms of time and resources. In fact, weighted RAND will likely be more costly than DIR in all those cases where identifying the individuals with the strongest claims to the available SLSR is easier than allocating to each of the involved individuals chances that are proportional to the strength of each of these individuals’ claims to such SLSR (e.g. Broome, 1984b; John and Millum, 2020). A proponent of the argument from convenience may object that when allocating SLSR, it is rarely convenient to attempt to identify which individuals have the strongest claims to such SLSR because the difference in the strength of distinct individuals’ claims to SLSR is typically ‘small compared with the cost of acquiring the additional information’ (Elster, 1988: 120, italics added; also Stone, 2014: 198, on putative cases where the relevant decision-makers could differentiate the strength of individuals’ claims ‘given further information, but obtaining that information would be too difficult or costly to justify making the effort’). The objection correctly notes that identifying which individuals have the strongest claims to SLSR may occasionally involve expensive and time-consuming evaluations. However, it is dubious that the difference in the strength of distinct individuals’ claims to SLSR is typically ‘small compared with the cost of acquiring the additional information’. For allocations of SLSR have crucial life-and-death implications whose normative relevance typically trumps the cost of acquiring the information required to identify which individuals have the strongest claims to SLSR (e.g. Calabresi and Bobbitt, 1978; Broome, 1984b; Kilner, 1990; Iapichino ). In this respect, it would be of limited import to allege that ‘time pressure and limited information [may make RAND] preferable to trying to make finer-grained [evaluations] within a group of […] similar patients’ (Emanuel : 2053). For the relevant decision-makers need time and resources to establish whether the involved individuals’ claims to SLSR are ‘similar’ in strength and how ‘similar’ in strength they are. And as I argue in the coming sections, the proponents of RAND are rarely able to demonstrate that individuals’ claims to SLSR are sufficiently similar in strength to justify using RAND (rather than DIR) to allocate SLSR. A proponent of the argument from convenience may further object that when allocating SLSR, RAND relieve the relevant decision-makers of ‘the responsibility of deciding who is to live and who to die [and of the associated] emotional burden’ (Broome, 1991a: 88, italics added; also Glover, 1977: 219). However, using RAND to allocate SLSR does not generally alleviate the relevant decision-makers’ emotional burden. For their decisions ‘will make all the difference between life and death anyway’ (Henning, 2015: 194) irrespective of whether they use RAND or DIR. Moreover, even if using RAND generally alleviated the relevant decision-makers’ emotional burden, the psychological benefits that using RAND (rather than DIR) putatively yields to the relevant decision-makers (while normatively relevant) would rarely trump the normative relevance of the differences in strength of different individuals’ claims to SLSR and these differences’ life-and-death implications. More generally, the point remains that the availability of RAND does not per se relieve the relevant decision-makers of the responsibility of assessing the strength of different individuals’ claims to the available SLSR. For even in those cases where they decide to use RAND, the relevant decision-makers are responsible for their decision to allocate SLSR on the basis of RAND rather than DIR. And in such cases, it is up to the relevant decision-makers to explicate on what grounds exactly individuals’ living or dying should be left to chance ‘when in so many other areas of human life we believe that we have an obligation to [allocate benefits and burdens on the basis of DIR]’ (Harris, 1975: 83; also Wolfle, 1970: 1201; Belliotti, 1980: 255).

Argument from Tie-Breaking

The argument from tie-breaking holds that the relevant decision-makers should use RAND (rather than DIR) to allocate SLSR on the alleged ground that RAND ‘are good tie breakers’, i.e. they are an effective ‘means of getting the decision made [when the claims] of different candidates are exactly balanced’ (Broome, 1991a: 89; also Elster, 1988: 107–113; Goodwin, 1992). The idea is that in all situations where ‘two or more people have equal claims’ to SLSR, unweighted RAND are ‘the morally preferable way of allocating [SLSR]’ (Sher, 1980: 203; also Kornhauser and Sager, 1988; Stone, 2007, 2009). For in those situations, using allocation procedures other than unweighted RAND ‘is either to say that [the involved people’s] claims were not equal [or] to unjustly favour one of the equal claims over the other on the basis of irrelevant differences’ (Saunders, 2008: 362). There are at least two reasons to doubt that the argument from tie-breaking justifies using RAND (rather than DIR) to allocate SLSR. First, the relevant decision-makers are not always able to establish whether different individuals’ claims to SLSR are equally strong. For the strength of individuals’ claims to SLSR depends on multiple factors, and it is frequently difficult to assess reliably the overall impact of such factors on the strength of individuals’ claims to SLSR (e.g. White ; Emanuel ; also ‘Argument from Incommensurability' on how this difficulty hampers the justifiability of various DIR). And second, in cases where the relevant decision-makers are able to reliably assess the strength of individuals’ claims to SLSR, different individuals’ claims rarely have exactly equal strength (e.g. Kirkpatrick and Eastwood, 2015: 87, claiming that situations where ‘the claims of two candidates are exactly equal and we know that their claims are exactly equal [are] incredibly rare’; also Broome, 1991a; Den Hartogh, 2004; Voorhoeve, 2014, on the frequent cases where individuals significantly differ in terms of medical need or likelihood to benefit from the available SLSR). In this respect, it would be of limited import to allege that in ‘matters of life and death […] everyone has a claim to life’ (Broome, 1991a: 99; also Kilner, 1981). For the alleged fact that all the involved individuals have a claim to life falls short of implying that such individuals have equally strong claims to SLSR (e.g. Fumagalli, 2018; also Broome, 1984b: 40, holding that ‘when choosing between people it will never in practice happen that all the considerations in favor of [each] candidate will exactly balance’). These considerations, in turn, cast doubt on the argument from tie-breaking’s potential to ground a wide-ranging case in favour of RAND. As Sher puts it, RAND’s role in ‘breaking a tie […] would be insignificant [since] it will hardly ever happen in practice that [claims] balance exactly. And if ever they do, the slightest change in one of them would mean they were no longer balanced’ (1980: 203; also Den Hartogh, 2004: 18). A proponent of the argument from tie-breaking may object that if one chooses to allocate SLSR directly to some individuals (rather than others), then one is treating some individuals’ lives as more worthy than others (e.g. Saunders, 2008: 362). Still, one may consistently hold that different individuals’ lives are equally worthy, yet maintain that these individuals’ claims to specific SLSR differ in strength (e.g. Broome, 1994: 36–37). In this respect, it would be implausible to hold that since individuals’ lives are equally worthy, individuals should be given equal chances of receiving SLSR even when their claims significantly differ in strength (e.g. Waring, 2004: ch. 1). For the alleged fact that individuals’ lives are equally worthy falls short of implying that the relevant decision-makers can justifiably disregard major differences in the strength of distinct individuals’ claims to SLSR (e.g. think of major differences in medical need and expected benefits from treatment). And whenever the relevant decision-makers can identify major differences in the strength of distinct individuals’ claims to SLSR, ‘selecting randomly is [neither] a way of refusing to judge between people […] nor is it a way of affirming people’s equal worth as human beings’ (Broome, 1984b: 52). A proponent of the argument from tie-breaking may further object that, in concrete allocation problems, decision-makers often reach a point where they are unable to reliably identify any major differences in the strength of distinct individuals’ claims to SLSR (e.g. Rescher, 1969; White , on two-stage procedures where one first uses DIR to narrow down the set of potential candidates and then singles out the actual patients within this group by means of RAND). The idea is that one can justifiably use RAND as tie-breakers when allocating SLSR among individuals who are ‘tied within the limits of comparability’ (Broome, 1991a: 101; also Stone, 2013: 591, holding that in many situations, individuals’ claims are ‘so similar’ that the relevant decision-makers ‘are more likely to [wrongfully distinguish] among candidates with equal claims [than they are to reliably distinguish] among candidates with unequal claims’). This objection correctly notes that in some situations, the relevant decision-makers are unable to reliably identify major differences in the strength of distinct individuals’ claims to SLSR (e.g. Savulescu, 1998). Still, in many real-life allocation problems, the relevant decision-makers can reliably identify differences that are significant enough to break putative ties between individuals (e.g. the coming sections on major differences in medical need and various clinical factors; also Fumagalli, 2020, on decision-makers’ ability to identify morally significant differences across several policy contexts). Whenever this is the case, carefully designed and implemented DIR are more likely than RAND to allocate SLSR to individuals having comparatively stronger claims to such SLSR (e.g. ‘Argument from Fairness'). Moreover, even in cases where the relevant decision-makers are unable to identify differences that are significant enough to break putative ties between individuals, it is questionable whether RAND are uniquely justified to break those ties. For in such cases, many allocation procedures that do not involve any kind of RAND may be justifiably used to break ties (e.g. Ullmann-Margalit and Morgenbesser, 1977, on various so-called picking procedures). In this respect, it is telling that leading proponents of RAND concede that when allocating SLSR, ‘it is doubtful that [RAND are] going to be the best way of breaking the tie’ (Broome, 1991a: 101). A proponent of the argument from tie-breaking may further object that RAND ‘become live options only after some effort to [filter] out options has taken place’ (Stone, 2011: 149, italics added; also Elster, 1989: 67, claiming that ‘I know of no instance of social lotteries without some preselection […] on the basis of need, merit, and the like’). This objection correctly notes that RAND are rarely implemented without some preliminary screening of the involved individuals’ claims to the available SLSR. Still, the objection fails to ground a wide-ranging case in favour of RAND unless it is supplemented with plausible and detailed criteria to establish what level of preliminary screening is adequate. In this respect, it would be of limited import to contend that RAND are justifiably used ‘after the “right” amount of work has been done by reasons’ and that the relevant decision-makers should use RAND whenever ‘the dangers posed by bad reasons outweigh the benefits offered by good reasons’ (Stone, 2011: 150, italics added). For these contentions do not specify what the ‘right’ amount of work consists in, and leave unclear how the relevant decision-makers are supposed to demarcate ‘good’ and ‘bad’ reasons and how they should resolve disagreements about this demarcation issue. Moreover, DIR are not the only allocation procedures that face the risk of grounding allocations of SLSR on reasons that do not bear on the strength of individuals’ claims to SLSR. For weighted RAND also face such risk (e.g. Stone, 2013). And unweighted RAND face the opposite—and often more troublesome—risk of failing to track reasons that decisively bear on the strength of individuals’ claims to SLSR (e.g. Teira, 2013a).

Argument from Equal Chances

The argument from equal chances holds that the relevant decision-makers should use RAND (rather than DIR) to allocate SLSR on the alleged ground that when different individuals have equally strong claims to SLSR and dividing SLSR is not possible (or substantially decreases their expected benefits), ‘justice demands that each person receive an “equal chance” at getting [SLSR]’ (Stone, 2007: 281; also Stone, 2011: 17). The idea is that RAND have ‘the unique capacity to divide a good probabilistically’ (Kornhauser and Sager, 1988: 491) and enable the relevant decision-makers to substitute equality of outcomes with equality of chance, which is a ‘second-best equity’ (Duxbury, 1999: 72–73) and a ‘surrogate satisfaction’ of the individuals’ claims to SLSR (Broome, 1991a: 98; also Elster, 1988: 128; Saunders, 2008: 359). There are at least two reasons to doubt that the argument from equal chances justifies using RAND (rather than DIR) to allocate SLSR. First, as noted in ‘Argument from Tie-Breaking', the proponents of RAND are rarely able to establish that different individuals’ claims to SLSR have equal strength. This, in turn, casts doubt on the argument from equal chances’ potential to ground a wide-ranging case in favour of RAND. In particular, it indicates that the allocative decision to give each of the involved individuals the same chance of receiving the available SLSR ‘requires justifying as much as any other’ allocative decision (Broome, 1984b: 54). And second, whenever the relevant decision-makers have reason to think that the involved individuals’ claims to the available SLSR significantly differ in strength, it is dubious that giving each of the involved individuals the same chance of receiving this SLSR has the normative relevance required to justify using RAND to allocate such SLSR. In fact, it is hard to see in what sense ‘chances of satisfaction [would constitute] surrogate satisfaction, so that giving people equal chances would constitute a way to treat [people’s] claims fairly’ (Henning, 2015: 177, italics added; also Lazenby, 2014: 337, holding that giving one some chance of receiving a good does not per se provide her with any ‘satisfaction of her claim […] commensurate with satisfaction in outcome’). A proponent of the argument from equal chances may object that ‘the provision of […] epistemically equal positive chances of an indivisible, life-saving resource to those with equal claims […] ensures the equal distribution of something that it is rational for different individuals to prudentially value equally’ (Otsuka, 2021, italics added; also Parfit, 2003: 376–378). This objection correctly notes that the involved individuals might regard their chances of receiving SLSR as intrinsically (rather than just instrumentally) valuable (e.g. Goldschmidt and Nissan-Rozen, 2021). Still, the chances given by RAND do not directly benefit the involved individuals in a way that makes it prudentially rational for these individuals to value an equal distribution of chances. In particular, it is not generally the case that ‘the chance of a benefit is itself a benefit’ (Saunders, 2008: 367; also Broome, 1984a; Wasserman, 1996). In fact, it would be mistaken to generally regard the chances given by RAND as an additional good to be added to the expected benefit of receiving SLSR (e.g. Henning, 2015: 174, holding that it would ‘be double counting to regard the chances provided by [RAND] as additional goods’). A proponent of the argument from equal chances may further object that ‘though the chance of a benefit is not itself a benefit […] we should not ignore such chance’ (Parfit, 2003: 377). In particular, she may maintain that when allocating SLSR, differences in the strength of different individuals’ claims to the available SLSR are often of minor normative relevance compared to the importance of giving each of the involved individuals equal chances of receiving such SLSR (e.g. Harris, 1999; Segev, 2005). The idea is that the relevant decision-makers should use unweighted RAND to allocate SLSR on the alleged ground that the importance of giving each of the involved individuals equal chances trumps the normative relevance of the differences in the strength of these individuals’ claims. However, when allocating SLSR, the importance of giving each of the involved individuals equal chances rarely trumps the normative relevance of the differences in the strength of these individuals’ claims. For as noted in the previous sections, there frequently are major differences in the strength of distinct individuals’ claims to SLSR, and allocations of SLSR often have life-and-death implications whose normative relevance trumps the importance of giving each of the involved individuals equal chances. To put it differently, when the relevant decision-makers can identify major differences in the strength of distinct individuals’ claims to SLSR, the reason to prefer individuals with comparatively stronger claims outweighs the importance of giving each individual an equal chance (e.g. Savulescu, 1998; Stein, 2002). In this respect, it would be of limited import for a proponent of the argument from equal chances to object that if individuals’ claims significantly differ in strength, then the relevant decision-makers can track such difference by relying on weighted (rather than unweighted) RAND (e.g. Broome, 1991a: 98). For weighted RAND do not give each of the involved individuals an equal chance of receiving the available SLSR and face severe difficulties when it comes to apportioning each individual’s chance of receiving the available SLSR to the strength of each individual’s claim to such SLSR (e.g. Kirkpatrick and Eastwood, 2015: 82, holding that ‘it is almost impossible to calculate the weights of the lotteries in accordance with the [strength of each individual’s claim]’; also the previous sections).

Argument from Fairness

The argument from fairness holds that the relevant decision-makers should use RAND (rather than DIR) to allocate SLSR on the alleged ground that RAND are typically fairer than DIR and are ‘sometimes […] the fairest way of distributing a good’ (Broome, 1991a: 87–88; also Rowe, 2021). The idea is that RAND yield a fairness gain compared to DIR because fairness ‘requires that each candidate’s claim should be satisfied in proportion to its strength’ and RAND satisfy this requirement better than DIR (Broome, 1994: 38; also Broome, 1984b: 45, 1991a: 95). To be sure, the argument grants that RAND involve a fairness loss compared to DIR in that they are less likely than DIR to allocate SLSR to individuals with comparatively stronger claims to SLSR (e.g. Broome, 1984b). Still, the argument holds that this fairness loss must ‘be weighed against [RAND’s] contribution to fairness’ and that ‘if claims are close to equality, holding [RAND] will be fairer than not’ (Broome, 1991a: 99; also Stone, 2011: 88, holding that when the involved individuals have ‘equal claims […] it is impossible to imagine anything fairer’ than RAND). Hence, the argument goes, when allocating SLSR, RAND are typically justified because in ‘matters of life and death, fairness is particularly important [and] everyone has a claim to life’ (Broome, 1991a: 90 and 99). That is to say, when claims are equal, one should use unweighted RAND, and when claims are not equal, one should use weighted RAND, with heavier weights assigned to the individuals with stronger claims to the available SLSR (e.g. Broome, 1991a; White and Angus, 2020; Rowe, 2021). There are at least two reasons to doubt that the argument from fairness justifies using RAND (rather than DIR) to allocate SLSR. First, as the argument acknowledges, fairness is not the only factor which bears on the justifiability of using RAND (rather than DIR) to allocate SLSR (e.g. Broome, 1991a: 99, holding that the justifiability of using RAND will depend on ‘how important fairness is’ compared to the issue whether ‘the candidates’ claims are equal’). And for all the argument shows, fairness considerations may frequently fail to trump other factors when assessing the justifiability of different procedures for allocating SLSR (e.g. Schmidt, 1994; Nissan-Rozen, 2019; Savulescu , on various cases where major social welfare gains override the demands of fairness). And second, the argument does not show that allocating SLSR on the basis of RAND is generally fairer than allocating SLSR on the basis of DIR. This point can be explicated as follows. Several conceptions of fairness have been advocated in the recent literature on the allocation of scarce resources (e.g. Fleurbaey, 2008; Otsuka and Voorhoeve, 2009; Fleurbaey and Maniquet, 2011). Few of the proffered conceptions endorse the argument from fairness’ presupposition that fairness requires that each candidate’s claim should be satisfied in proportion to its strength (e.g. Saunders, 2010; Tomlin, 2012; Voorhoeve and Fleurbaey, 2012). In fact, various conceptions hold that when individuals’ claims to SLSR significantly differ in strength, it would be unfair to allocate SLSR using RAND (e.g. Voorhoeve, 2014; also Stone, 2011: 150, holding that it would be unfair to ‘toss […] a coin before deciding whether [to cure] a moderately sick or critically ill person’). For in presence of significant differences in the strength of individuals’ claims, the fairness gain that RAND putatively yield compared to DIR does not offset the fairness loss occurring whenever individuals with comparatively weaker claims receive the available SLSR. As Hooker puts it, ‘suppose your claims to some indivisible good are very much [stronger] than mine. Is there any unfairness in your getting the indivisible good rather than my getting it? […] Given that your claim is so much stronger than mine […] letting the stronger claim win seems completely fair’ (2005: 349). A proponent of the argument from fairness may object that the argument justifies using RAND (rather than DIR) to allocate SLSR on the alleged ground that any change in the strength of the involved individuals’ claims to SLSR ‘warrant[s] a similarly-sized change to what fairness requires’ (Rowe, 2021: 1, italics added). I am not persuaded that any change in the strength of the involved individuals’ claims to SLSR warrants ‘a similarly-sized change to what fairness requires’. For the fairness loss involved in using RAND (rather than DIR) increases as the difference in the strength of the involved individuals’ claims increases. And for all the argument from fairness shows, RAND may be overall fair only when the involved individuals have claims of the same strength (e.g. Lazenby, 2014: 344; also Saunders, 2010; Voorhoeve, 2014; Kirkpatrick and Eastwood, 2015, on cases where the difference in the strength of distinct individuals’ claims to SLSR is so large that it seems rather unfair to use RAND to decide which individuals receive such SLSR). This, in turn, significantly constrains the argument from fairness’ potential to ground a wide-ranging case in favour of RAND. For as argued in the previous sections, individuals’ claims rarely have the same strength . Moreover, even assuming that any change in the strength of the involved individuals’ claims to SLSR warranted ‘a similarly-sized change to what fairness requires’, this assumption would not per se license the conclusion that any change in the strength of the involved individuals’ claims to SLSR warrants a similarly-sized change in the chance that each of the involved individuals should have of receiving SLSR. A proponent of the argument from fairness may further object that the argument ‘can be extended’ from cases where candidates have ‘exactly equal claims’ to SLSR to cases where they have ‘roughly equal claims’ to SLSR, thereby vindicating the use of RAND in ‘a much wider domain’ (Broome, 1984b: 48, italics added; also Rowe, 2021, on cases where decision-makers are unable to reliably identify major differences in the strength of individuals’ claims). The idea is that the argument from fairness justifies using RAND (rather than DIR) to allocate SLSR unless the involved individuals’ claims significantly differ in strength and enables the relevant decision-makers to identify clear cases where using RAND is justified. To illustrate this objection, consider the following scenario (e.g. Piller, 2017: 230, for a similar illustration). Assume, for the sake of argument, that we can reliably measure the strength of individuals’ claims to SLSR on some cardinal scale. Compare then a large-difference case where a 99 per cent to 1 per cent distribution of the chances of receiving SLSR reflects the strength of two individuals’ claims to SLSR, with a small-difference case where a 51 per cent to 49 per cent distribution of the chances of receiving SLSR reflects the strength of two individuals’ claims to SLSR. The argument from fairness does not recommend using RAND in the large-difference case since the fairness loss which occurs when using DIR that reduce the chance of the individual with the rather weak claim from 1 per cent to 0 per cent is negligible. Conversely, the argument from fairness recommends using weighted RAND in the small-difference case on the alleged ground that using DIR that reduce the chance of the individual with the slightly weaker claim from 49 per cent to 0 per cent is less fair than using RAND that give such individual a 49 per cent chance of receiving SLSR. The idea is that in the small-difference case, allocating SLSR directly to the individual with the slightly stronger claim would be unfair because the individual with the slightly weaker claim ‘is entitled to treatment only slightly less good’ than the individual with the slightly stronger claim rather than a 0 per cent chance of receiving SLSR (Broome, 1984b: 48). This objection invites two rejoinders. First, the mere fact that DIR give the individual who would otherwise have a 49 per cent chance of receiving SLSR a 0 per cent chance of receiving SLSR does not per se make DIR unfair. In fact, the argument from fairness presupposes (rather than shows) that fairness requires to give such individual a 49 per cent chance of receiving SLSR. In particular, the argument fails to undermine conceptions of fairness according to which, when the relevant decision-makers can reliably identify differences in the strength of distinct individuals’ claims to SLSR, fairness requires giving SLSR directly to the individuals with the strongest claims to SLSR rather than giving all the involved individuals chances proportional to the strength of these individuals’ claims to SLSR. And second, the argument from fairness does not provide plausible and detailed criteria to establish exactly when the difference between stronger and weaker claims can be justifiably regarded as small enough that the fairness gain putatively yielded by RAND trumps the unfairness which occurs whenever the individuals with comparatively weaker claims receive SLSR. Hence, the argument does not provide plausible and detailed criteria to establish in what situations RAND are fairer than DIR.

Argument from Incommensurability

The argument from incommensurability holds that the relevant decision-makers should use RAND (rather than DIR) to allocate SLSR on the alleged ground that ‘when comparing candidates for life-saving treatment […] it often seems impossible to weigh the [candidates’ claims to treatment] in a precise way’ (Broome, 1991a: 100; also Glover, 1977: 203–227). The idea is that the strength of different individuals’ claims to SLSR is often incommensurable (e.g. Rescher, 1969; Raz, 1999: ch. 3) and that whenever it is ‘impossible in practice to carry out finely grained comparisons’ of the strength of individuals’ claims to SLSR, the relevant decision-makers should allocate SLSR on the basis of RAND (Elster, 1988: 131; also Broome, 1984b: 50, holding that ‘there are many possible criteria’ for choosing between the involved individuals, and ‘there may not even be any single correct way of weighing up the criteria’). There are at least three reasons to doubt that the argument from incommensurability justifies using RAND (rather than DIR) to allocate SLSR. First, showing that the strength of different individuals’ claims to SLSR is incommensurable requires one to show that reliable comparisons of the strength of such claims are ‘impossible […] not just costly or difficult’ (Elster, 1988: 163, italics added). Yet, the proponents of the argument from incommensurability have hitherto failed to show that cases of incommensurability are sufficiently widespread to ground a wide-ranging case in favour of RAND. Second, it is dubious that cases of incommensurability are sufficiently widespread to ground a wide-ranging case in favour of RAND. For as illustrated in the previous sections, the difficulties inherent in assessing the strength of different individuals’ claims to SLSR rarely prevent decision-makers from being able to make some informed ordinal judgements regarding the strength of different individuals’ claims to SLSR. To give one example, consider decision-makers’ judgements of medical need. When allocating SLSR, it is often difficult to assess how exactly the involved individuals differ in terms of medical need. Still, this difficulty does not prevent the relevant decision-makers from being able to make some informed ordinal judgements regarding individuals’ medical need and how considerations of medical need bear on the strength of those individuals’ claims to SLSR (e.g. Broome, 1984b; also Antommaria ; Chisholm, 2020). And third, deciding which RAND to use to allocate SLSR (e.g. weighted versus unweighted RAND, which weighted or unweighted RAND) requires the relevant decision-makers to assess the strength of different individuals’ claims to SLSR. Hence, pointing to the alleged incommensurability of the strength of different individuals’ claims to SLSR does not per se provide a reason to regard RAND as more justified than DIR. As leading proponents of RAND acknowledge, justifying RAND requires one ‘to establish a rank ordering’ among the involved individuals’ claims, and ‘if the claims are incommensurable […] it is unclear precisely what allocative justice demands’ (Stone, 2011: 56). A proponent of the argument from incommensurability may object that the relevant decision-makers should use RAND (rather than DIR) to allocate SLSR on the alleged ground that ‘when an agent is unsure what the morally right thing to do is [then using RAND] is the best one can do, given one’s moral uncertainty’ (Nissan-Rozen, 2012: 45–46, italics added; also Rescher, 1969). The idea is that the relevant decision-makers often find it epistemically impossible to identify what procedure it is morally right to use to allocate SLSR and that whenever this is the case, ‘the only rational thing’ for the decision-makers is to use RAND even though the decision-makers have reason to think that there is some other allocation available which is morally better (Nissan-Rozen, 2012: 49). This objection aptly emphasizes the uncertainty that is often involved in identifying what procedure it is morally right to use to allocate SLSR, but does not ground a wide-ranging case in favour of RAND. For as its proponents grant (e.g. Nissan-Rozen, 2012: 45), the objection recommends using RAND only when the relevant decision-makers find it epistemically impossible to identify what procedure it is morally right to use to allocate SLSR. And the relevant decision-makers can frequently resolve (or at least alleviate) their moral uncertainty by acquiring more information about the allocation problems they face (e.g. which RAND and DIR can be feasibly adopted, what consequences the available allocations may have, and what value different normative theories assign to such allocations). A proponent of the argument from incommensurability may further object that the relevant decision-makers are often unable to resolve their moral uncertainty by acquiring more information about the allocation problems they face (e.g. Hersch and Rowe, 2021, on cases where the relevant decision-makers disagree as to what criteria should be adopted to assess the strength of the involved individuals’ claims). The idea is that there are limits to decision-makers’ ability to identify all the reasons that bear on the strength of individuals’ claims to SLSR and that ‘these limits provide reasons for accepting regular use of [RAND]’ (Stone, 2013: 579, italics added; also Stone, 2011, 105, holding that many calls for DIR betray ‘extraordinary confidence in what reason can do’). This objection invites two rejoinders. First, one may consistently advocate DIR while acknowledging that the relevant decision-makers may be unable to identify all the reasons that bear on the strength of individuals’ claims to SLSR (e.g. ‘Argument from Convenience' on situations of unforeseen emergency). For justifying DIR does not require decision-makers to identify all the reasons that bear on the strength of individuals’ claims to SLSR, but only requires them to identify the main reasons that bear on the strength of such claims. To be sure, if decision-makers identify only a few of the reasons that bear on the strength of individuals’ claims to SLSR, then it is possible that some unidentified reasons offset the impact that the identified reasons have on the allocation of the available SLSR. Still, if the proponents of RAND are to show that the RAND they advocate are more justified than DIR, then it is up to them to point to unidentified reasons and demonstrate that such reasons do (or at least likely) offset the impact that the identified reasons have on allocation. And second, it is often calls for RAND (rather than calls for DIR) which rest on unsupported presuppositions concerning decision-makers’ evaluative abilities. By way of illustration, calls for RAND commonly infer that, if the relevant decision-makers do not happen to find any significant difference in the strength of the involved individuals’ claims to SLSR, then they can justifiably treat these individuals’ claims as if they have equal strength (e.g. Stone, 2009: 395–396). And in many cases, this inference only seems plausible under the presupposition—often left unsupported—that decision-makers’ assessment of the strength of the involved individuals’ claims to SLSR identifies all the main reasons that bear on the strength of these individuals’ claims.

Argument from Unjust Discrimination

The argument from unjust discrimination holds that the relevant decision-makers should use RAND (rather than DIR) to allocate SLSR on the alleged ground that DIR are often unjustly discriminatory (e.g. Stone, 2013; Chisholm, 2020), whereas RAND ‘can [ensure] that bad reasons be kept out of the decision’ (Stone, 2011: vii; also Dowlen, 2008: 15; Saunders, 2008: 359). The idea is that the relevant decision-makers should use RAND (rather than DIR) to allocate SLSR because RAND are less vulnerable than DIR to unjustly discriminatory (e.g. racist) biases and ‘are constitutionally incapable of playing favorites’ (Goodin, 1988: 61; also Kornhauser and Sager, 1988; Stone, 2009, 2011, on the ‘sanitizing’ function of lotteries, which putatively prevents unjustly discriminatory reasons from influencing allocation decisions). There are at least two reasons to doubt that the argument from unjust discrimination justifies using RAND (rather than DIR) to allocate SLSR. First, a number of factors can make a significant difference to the allocation of SLSR across distinct groups of individuals without being unjustly discriminatory (e.g. Lippert-Rasmussen, 2013: ch. 1–2). To illustrate this, consider the issue whether SLSR should be allocated on the basis of individuals’ age. Several proposals for allocating SLSR recommend prioritizing the young over the elderly in cases of pandemic emergency where being above a particular age makes individuals significantly less likely to benefit from SLSR (e.g. White and Lo, 2020; British Medical Association, 2020b). Allocating SLSR directly on the basis of individuals’ age is often regarded as unjustly discriminatory (e.g. Popescu and Marcoci, 2020; also Bognar, 2015; Nielsen, 2021, for discussion). Still, the fact that grounding the allocation of SLSR on individuals’ capacity to benefit from SLSR may disadvantage the elderly does not per se make such allocation proposals unjustly discriminatory (e.g. Farrelly, 2008; Lazenby, 2011; British Medical Association, 2020a). And second, the fact that discriminatory biases do affect some DIR (e.g. Den Hartogh, 2010; Hersch and Rowe, 2021, on cases where first-come first-served and waiting time favour socio-economically privileged individuals) does not cast general doubt on the justifiability of DIR. For the proponents of DIR frequently have the means to neutralize (or at least alleviate) the influence of discriminatory biases (e.g. Antommaria ; Truog , on blinding mechanisms to prevent the relevant decision-makers from accessing clinically irrelevant information about individuals’ race and wealth; also British Medical Association, 2020b; White and Lo, 2020, on allocation criteria that explicitly prohibit allocating SLSR on the basis of clinically irrelevant information about individuals’ socio-economic status, ethnicity and sexual orientation). Hence, pointing to some DIR’s vulnerability to discriminatory biases does not per se indicate that the relevant decision-makers should allocate SLSR on the basis of RAND. A proponent of the argument from unjust discrimination may object that the relevant decision-makers should use RAND (rather than DIR) to allocate SLSR on the alleged ground that RAND are more effective than DIR in preventing the relevant decision-makers ‘from [engaging in] arbitrary exercise of power’ (Elster, 1988: 166). The idea is that RAND ‘limit the opportunities for corruption and prejudice in decision making [and] guard against partiality and oppression’ (Broome, 1984b: 40; also Stone, 2011: 82). This objection aptly emphasizes the importance of countering the influence of decision-makers’ potential biases and corruption on the design and the implementation of allocation procedures (e.g. Sher, 1980; Teira, 2013b). However, the objection fails to show that RAND are generally more effective than DIR in countering the influence of decision-makers’ potential biases and corruption (e.g. think of transparency and accountability concerns pertaining to the decision-makers who design and implement the proffered RAND). In fact, various sources of biases and corruption (e.g. racist attitudes) may demonstrably influence both decision-makers’ calibration of the weights to be adopted in RAND and decision-makers’ judgements as to whether the conditions which putatively justify using RAND (rather than DIR) are satisfied in the first place (e.g. Broome, 1991a: 88; Henning, 2015: 183). A proponent of RAND may further object that the procedures for allocating specific SLSR are often designed and implemented in contexts facing structural discrimination (e.g. think of deep and persistent socio-economic inequalities) and that RAND are generally more effective than DIR in correcting for such discrimination. The idea is that ‘we cannot, nor should we, expect that health-care workers […] redress the social determinants of ill health’ and that in light of existing socio-economic inequalities ‘it seems somewhat disingenuous to pretend that [DIR are not influenced by] the social determinates of health’ (Silva, 2020: 891). Let us assume, for the sake of argument, that the justifiability of the procedures for allocating specific SLSR depends on how effectively these procedures correct for structural discrimination. Even so, it is dubious that RAND are generally more effective than DIR in correcting for structural discrimination. For only DIR and weighted RAND can be calibrated with the specific aim to correct for structural discrimination. And unweighted RAND occasionally tend to exacerbate (rather than correct for) structural discrimination (e.g. John and Millum, 2020, for illustrations targeting iterated applications of unweighted RAND).

Conclusion

In this paper, I have provided a systematic categorization and a critical evaluation of the most influential arguments put forward to support the use of RAND to allocate SLSR. I have argued that these arguments justify using RAND to allocate SLSR in fewer cases than their proponents maintain and that the relevant decision-makers should typically allocate SLSR directly to the individuals with the strongest claims to SLSR rather than use RAND to allocate SLSR. This result does not per se exclude that some further arguments may be articulated which support using RAND to allocate specific SLSR. Still, it makes it pressing for the proponents of RAND to articulate and support those arguments. In the absence of such arguments, the relevant decision-makers should typically allocate SLSR directly to the individuals with the strongest claims to these resources rather than use RAND to allocate such resources.

Conflict of Interest

None declared.
  37 in total

1.  Utility and the survival lottery.

Authors:  Peter Singer
Journal:  Philosophy       Date:  1977-04

2.  Selecting people randomly.

Authors:  John Broome
Journal:  Ethics       Date:  1984-10

3.  An ethically defensible market in organs.

Authors:  John Harris; Charles Erin
Journal:  BMJ       Date:  2002-07-20

4.  Chance, or human judgment?

Authors:  D Wolfle
Journal:  Science       Date:  1970-02-27       Impact factor: 47.728

5.  The Toughest Triage - Allocating Ventilators in a Pandemic.

Authors:  Robert D Truog; Christine Mitchell; George Q Daley
Journal:  N Engl J Med       Date:  2020-03-23       Impact factor: 91.245

6.  Contractualist age rationing under outbreak circumstances.

Authors:  Lasse Nielsen
Journal:  Bioethics       Date:  2020-10-17       Impact factor: 1.898

7.  Currents in contemporary ethics. Should health care providers get treatment priority in an influenza pandemic?

Authors:  Mark A Rothstein
Journal:  J Law Med Ethics       Date:  2010       Impact factor: 1.718

8.  Slipping on slippery slope arguments.

Authors:  Roberto Fumagalli
Journal:  Bioethics       Date:  2020-03-02       Impact factor: 1.898

9.  Fairness versus doing the most good.

Authors:  J Broome
Journal:  Hastings Cent Rep       Date:  1994 Jul-Aug       Impact factor: 2.683

10.  Reasons for refusal of admission to intensive care and impact on mortality.

Authors:  Gaetano Iapichino; Davide Corbella; Cosetta Minelli; Gary H Mills; Antonio Artigas; David L Edbooke; Angelo Pezzi; Jozef Kesecioglu; Nicolò Patroniti; Mario Baras; Charles L Sprung
Journal:  Intensive Care Med       Date:  2010-06-09       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.